Sara Hernández-Ortega

Sara Hernández-Ortega

Auto-generated profile, based on publicly available information

Sara Hernández-Ortega

Sant Joan de Déu Research Institute, Esplugues de Llobregat, Spain

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2021 in JMIR Formative Research
Verified
Journal Article
Open access
RRRoxana Radu
Roxana Radu
SHSara Hernández-Ortega
Sara Hernández-Ortega
OBOriol Borrega
Oriol Borrega
VSVolker Straub
Volker Straub
DADimitrios Athanasiou
Dimitrios Athanasiou
BEBegonya Nafria Escalera
Begonya Nafria Escalera
Background: Rare disease communities are spread around the globe and segmented by their condition. Little research has been performed on the majority of rare diseases. Most patients who are affected by a rare disease have no research on their condition because of a lack of knowledge due to absence of common groups in the research community. Objective: We aimed to develop a safe and secure community of rare disease patients, without geographic or language barriers, to promote research. Methods: Cocreation design methodology was applied to build Share4Rare, with consultation and input through workshops from a variety of stakeholders (patients, caregivers, clinicians, and researchers). Results: The workshops allowed us to develop a layered version of the platform based on educating patients and caregivers with publicly accessible information, a secure community for the patients and caregivers, and a research section with the purpose of collecting patient information for analysis, which was the core and final value of the platform. Conclusions: Rare disease research requires global collaboration in which patients and caregivers have key roles. Collective intelligence methods implemented in digital platforms reduce geographic and language boundaries and involve patients in a unique and universal project. Their contributions are essential to increase the amount of scientific knowledge that experts have on rare diseases. Share4Rare has been designed as a global platform to facilitate the donation of clinical information to foster research that matters to patients with rare conditions. The codesign methods with patients have been essential to create a patient-centric design.

7 August 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ASAbril Sánchez-Botet
Abril Sánchez-Botet
LGLaura Gasa
Laura Gasa
EQEva Quandt
Eva Quandt
SHSara Hernández-Ortega
Sara Hernández-Ortega
JJJavier Jiménez
Javier Jiménez
JCJosep Clotet
Josep Clotet
Colorectal cancer (CRC) is one of the most common cancers worldwide, with 8–10% of these tumours presenting a BRAF (V600E) mutation. Cyclins are known oncogenes deregulated in many cancers, but the role of the new subfamily of atypical cyclins remains elusive. Here we have performed a systematic analysis of the protein expression levels of eight atypical cyclins in human CRC tumours and several cell lines, and found that CNTD2 is significantly upregulated in CRC tissue compared to the adjacent normal one. CNTD2 overexpression in CRC cell lines increases their proliferation capacity and migration, as well as spheroid formation capacity and anchorage-independent growth. Moreover, CNTD2 increases tumour growth in vivo on xenograft models of CRC with wild-type BRAF. Accordingly, CNTD2 downregulation significantly diminished the proliferation of wild-type BRAF CRC cells, suggesting that CNTD2 may represent a new prognostic factor and a promising drug target in the management of CRC.

21 July 2020 in JMIR Preprints
Verified
Preprint
Open access
RRRoxana Radu
Roxana Radu
SHSara Hernández-Ortega
Sara Hernández-Ortega
OBOriol Borrega
Oriol Borrega
VSVolker Straub
Volker Straub
DADimitrios Athanasiou
Dimitrios Athanasiou
BEBegonya Nafria Escalera
Begonya Nafria Escalera
BACKGROUND Rare disease communities are spread around the globe and segmented by their condition. Little research has been performed on the majority of rare diseases. Most patients who are affected by a rare disease have no research on their condition because of a lack of knowledge due to absence of common groups in the research community. OBJECTIVE We aimed to develop a safe and secure community of rare disease patients, without geographic or language barriers, to promote research. METHODS Cocreation design methodology was applied to build Share4Rare, with consultation and input through workshops from a variety of stakeholders (patients, caregivers, clinicians, and researchers). RESULTS The workshops allowed us to develop a layered version of the platform based on educating patients and caregivers with publicly accessible information, a secure community for the patients and caregivers, and a research section with the purpose of collecting patient information for analysis, which was the core and final value of the platform. CONCLUSIONS Rare disease research requires global collaboration in which patients and caregivers have key roles. Collective intelligence methods implemented in digital platforms reduce geographic and language boundaries and involve patients in a unique and universal project. Their contributions are essential to increase the amount of scientific knowledge that experts have on rare diseases. Share4Rare has been designed as a global platform to facilitate the donation of clinical information to foster research that matters to patients with rare conditions. The codesign methods with patients have been essential to create a patient-centric design.